Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Brain Injuries D001930 4 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Anderson MR and Blumer JL Advances in the therapy for sepsis in children. 1997 Pediatr. Clin. North Am. pmid:9057790
Eigenmann PA Mechanisms of food allergy. 2009 Pediatr Allergy Immunol pmid:19154253
Svetlov SI and SerebrianyÄ­ VL [Thrombocyte activation factor: biochemical and pathophysiologic aspects]. 1989 Jan-Feb Patol Fiziol Eksp Ter pmid:2497431
Liu BN [Neoplastic membrane-toxic activity as one of the pathogenetic factors in blood cell and tumor growth changes]. 1987 Jan-Feb Patol Fiziol Eksp Ter pmid:3550649
Tuluevskaia LM et al. [Role of platelet activating factor in sensitization formation]. 1993 Mar-Apr Patol Fiziol Eksp Ter pmid:8058391
Sakamoto H et al. Stimulation of leukocyte phagocytic activity by the platelet release reaction. 1984 Pathology pmid:6462776
Hawkins NJ et al. The role of mesangial cells in glomerular pathology. 1990 Pathology pmid:2194156
Nunez D et al. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions]. 1987 Pathol. Biol. pmid:3550639
Martin M et al. [Antiretroviral ant anti-inflammatory properties of a novel platelet activation factor antagonist, PMS-601]. 2000 Pathol. Biol. pmid:10949851
McManus LM Pathobiology of platelet-activating factors. 1986 Pathol Immunopathol Res pmid:3543915
Borges AF et al. Platelet-activating factor increases reactive oxygen species-mediated microbicidal activity of human macrophages infected with Leishmania (Viannia) braziliensis. 2017 Pathog Dis pmid:28830073
Plotkowski MC et al. Contribution of the platelet activating factor signaling pathway to cerebral microcirculatory dysfunction during experimental sepsis by ExoU producing Pseudomonas aeruginosa. 2015 Pathog Dis pmid:26187894
Zimmermann LT et al. Effects of platelet-activating factor on the interaction of Trypanosoma cruzi with Rhodnius prolixus. 2011 Parasitol. Res. pmid:21161276
Camussi G et al. In vitro spasmogenic effect of platelet-activating factor on rabbit lung tissue. 1981 Jul-Sep Panminerva Med pmid:7335369
Souza LJ et al. Acute pancreatitis affects non-parenchymal liver cells by a mechanism dependent on platelet-activating factor. 2007 Pancreatology pmid:17449968
Haraldsen P et al. Multimodal management - of value in fulminant acute pancreatitis? 2003 Pancreatology pmid:12649560
Mann O et al. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity. 2009 Pancreas pmid:18695628
Yamaguchi Y et al. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. 1999 Pancreas pmid:10231840
Galloway SW and Kingsnorth AN Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist. 1996 Pancreas pmid:8829181
Leonhardt U et al. Effect of a platelet-activating factor antagonist on pancreas perfusion after 24 h of ischemia. 1995 Pancreas pmid:7479673
Andersson R et al. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats. 1998 Pancreas pmid:9700940
Kald B et al. Release of platelet-activating factor in acute experimental pancreatitis. 1993 Pancreas pmid:8361963
Zhang X et al. Effect of baicalin on inflammatory mediator levels and microcirculation disturbance in rats with severe acute pancreatitis. 2009 Pancreas pmid:19657312
Soybir G et al. The effects of free oxygen radical scavenger and platelet-activating factor antagonist agents in experimental acute pancreatitis. 1999 Pancreas pmid:10438161
Zia-Ul-Haq M et al. Report: Platelet aggregation inhibition activity of selected legumes of Pakistan. 2012 Pak J Pharm Sci pmid:23010006
Morita K et al. Glycinergic mediation of tactile allodynia induced by platelet-activating factor (PAF) through glutamate-NO-cyclic GMP signalling in spinal cord in mice. 2008 Pain pmid:18353555
Morita K et al. Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. 2004 Pain pmid:15363879
Tatsumi N et al. An anti-platelet activating factor antibody and its effects on platelet aggregation. 1993 Osaka City Med J pmid:8183536
Mizoguchi Y et al. The effect of lipo-prostaglandin E1 on the production of interleukin 1 and platelet-activating factor by hepatic sinusoidal endothelial cells in mice. 1991 Osaka City Med J pmid:1792067
Mizoguchi Y et al. Possible involvement of platelet-activating factor in the induction of liver cell injury. 1990 Osaka City Med J pmid:2074969
Tsuji H et al. The presence of platelet-activating factor-acetylhydrolase in human middle ear effusions. 1998 Jan-Feb ORL J. Otorhinolaryngol. Relat. Spec. pmid:9519378
Furukawa M et al. Evidence of platelet-activating factor in nasal polyps. 1992 ORL J. Otorhinolaryngol. Relat. Spec. pmid:1584590
Mi B and Maleczka RE A Nozaki-Hiyama-Kishi Ni(II)/Cr(II) coupling approach to the phomactins. 2001 Org. Lett. pmid:11388849
Mohr PJ and Halcomb RL Convergent enantioselective synthesis of the tricyclic core of phomactin A. 2002 Org. Lett. pmid:12098260
Houghton TJ et al. Efficient assembly of the phomactin core via two different macrocyclization protocols. 2001 Org. Lett. pmid:11700095
Chemler SR et al. Enantioselective synthesis of the oxadecalin core of phomactin A via a highly stereoselective Diels-Alder reaction. 2001 Org. Lett. pmid:11554815
Toró A et al. Transannular Diels-Alder studies on the asymmetric total synthesis of chatancin: the pyranophane approach. 2000 Org. Lett. pmid:10964353
Cole KP and Hsung RP Intramolecular formal oxa-[3 + 3] cycloaddition approach to the ABD system of phomactin A. 2003 Org. Lett. pmid:14653688
Kallan NC and Halcomb RL Synthesis of the ring system of phomactin D using a Suzuki macrocyclization. 2000 Org. Lett. pmid:10990428
Wang C et al. Total synthesis of (+/-)-paeonilide. 2006 Org. Lett. pmid:16737293
Shi YM et al. Lancolides, antiplatelet aggregation nortriterpenoids with tricyclo[6.3.0.0(2,11)]undecane-bridged system from Schisandra lancifolia. 2013 Org. Lett. pmid:24059675
Goldring WP and Pattenden G Total synthesis of (+/-)-phomactin G, a platelet activating factor antagonist from the marine fungus Phoma sp. 2004 Org. Biomol. Chem. pmid:14770224
Fodran P and Minnaard AJ Catalytic synthesis of enantiopure mixed diacylglycerols – synthesis of a major M. tuberculosis phospholipid and platelet activating factor. 2013 Org. Biomol. Chem. pmid:24191360
Diaper CM et al. A total synthesis of (+/-)-phomactin A. 2003 Org. Biomol. Chem. pmid:14664384
Coy B ED et al. The first diastereoselective synthesis of cinerins A-C, PAF-antagonistic macrophyllin-type bicyclo[3.2.1]octane neolignans, using a novel Pd-catalysed oxyarylation. 2010 Org. Biomol. Chem. pmid:20401372
Wiebe SH et al. Osteoclast activation in inflammatory periodontal diseases. 1996 Oral Dis pmid:8957930
Cluzel J et al. Inhibition of platelet-activating factor-induced retinal impairments by cholera and pertussis toxins. 1995 Ophthalmic Res. pmid:8538992
Doly M et al. Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730. 1993 Ophthalmic Res. pmid:8259265
Valli A et al. Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways. 2015 Oncotarget pmid:25605240
Sahu RP et al. Radiation therapy generates platelet-activating factor agonists. 2016 Oncotarget pmid:26959112
Clinical studies of IL-11, new platelet growth factor, presented. 1997 Oncology (Williston Park, N.Y.) pmid:9057177
Anandi VL et al. Platelet-activating factor promotes motility in breast cancer cells and disrupts non-transformed breast acinar structures. 2016 Oncol. Rep. pmid:26531049
Soldi R et al. Platelet-activating factor (PAF) induces the early tyrosine phosphorylation of focal adhesion kinase (p125FAK) in human endothelial cells. 1996 Oncogene pmid:8760293
Denizot Y et al. Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients. 2003 Oncogene pmid:14562051
Ohshige A et al. Increased platelet-activating factor-acetylhydrolase activity in the umbilical venous plasma of growth-restricted fetuses. 1999 Obstet Gynecol pmid:9932551
Kobayashi F et al. Platelet-activating factor-acetylhydrolase activity in maternal and umbilical venous plasma obtained from normotensive and hypertensive pregnancies. 1994 Obstet Gynecol pmid:8058231
Hemmings R et al. Platelet-activating factor acetylhydrolase activity in peritoneal fluids of women with endometriosis. 1993 Obstet Gynecol pmid:8423963
Erickson KL Dietary fat, breast cancer, and nonspecific immunity. 1998 Nutr. Rev. pmid:9481130
Karantonis HC et al. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits. 2006 Nutr Metab Cardiovasc Dis pmid:16580585
Nimjee SM et al. Translation and Clinical Development of Antithrombotic Aptamers. 2016 Nucleic Acid Ther pmid:26882082
Sasaki T et al. A distribution study of 11C platelet-activating factor (PAF) analogs in normal and tumor-bearing mice. 1996 Nucl. Med. Biol. pmid:8782242
MacIntyre DE et al. Endogenous and pharmacological mechanisms for the regulation of human platelet cytosolic free Ca2+. 1985 Nouv Rev Fr Hematol pmid:2997706
Roussi J et al. [Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia]. 1983 Nouv Rev Fr Hematol pmid:6622253
[Do you know PAF?]. 1980 Nouv Presse Med pmid:7367260
Oh-ishi S [Analysis of chemical mediators involved in acute inflammatory reaction with the rat pleurisy model]. 1997 Nippon Yakurigaku Zasshi pmid:9306414
Kakushi H et al. [Effect of cefaclor on guinea pig platelet aggregation in vitro]. 1990 Nippon Yakurigaku Zasshi pmid:2379885
Takehana Y et al. [Inhibitory effects of OKY-046.HCl, a selective thromboxane (TX) A2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness in guinea pigs]. 1990 Nippon Yakurigaku Zasshi pmid:2303203
Dohi T et al. [Role of platelet-activating factor on spinal pain transduction]. 2006 Nippon Yakurigaku Zasshi pmid:16508219
Morita K et al. [Pain relieving effect of platelet-activating factor (PAF) antagonists in a bone cancer pain model]. 2015 Nippon Yakurigaku Zasshi pmid:26256746
Sasaki Y et al. [Effect of KW-4679, a novel antiallergic drug, on platelet-activating factor (PAF)-induced bronchoconstriction, airway hyperresponsiveness and pulmonary cell accumulation in guinea pigs]. 1995 Nippon Yakurigaku Zasshi pmid:8566911
Fujikami F et al. [Positive and negative effects of progestins on platelet-activating factor acetylhydrolase activity in rat plasma]. 1995 Nippon Sanka Fujinka Gakkai Zasshi pmid:7608617
Takashima M et al. [Effects of estrogen and progestin on platelet-activating factor acetylhydrolase]. 1994 Nippon Sanka Fujinka Gakkai Zasshi pmid:8040619
Okawa T et al. [Endothelin-1-induced contraction of pregnant rat myometrium: role of platelet-activating factor]. 1994 Nippon Sanka Fujinka Gakkai Zasshi pmid:8308402
Kodama H et al. Isolation and identification of embryo-derived platelet-activating factor in mice. 1989 Nippon Sanka Fujinka Gakkai Zasshi pmid:2794622
Kikukawa Y et al. [The role of platelet activating factor in ovulation]. 1990 Nippon Sanka Fujinka Gakkai Zasshi pmid:2401830
Akada S et al. [The role of vitamin E during pregnancy--anti-platelet aggregation activity of alpha-tocopherol]. 1991 Nippon Sanka Fujinka Gakkai Zasshi pmid:2056228
Isogai E et al. [Platelet activating factor (PAF) and Lyme disease]. 1996 Nippon Saikingaku Zasshi pmid:8840817
Nagase T [Respiratory failure]. 2013 Nippon Rinsho pmid:23855209
Shimakura S et al. [Peptic ulcer and arachidonate cascade related compounds]. 1990 Nippon Rinsho pmid:1974655
Ito K [Thrombotic thrombocytopenic purpura--recent development of TTP study]. 1993 Nippon Rinsho pmid:8381882
[General aspects of cytokines]. 1990 Nippon Rinsho pmid:2214199
Deguchi K et al. [Platelet activating factor]. 1987 Nippon Rinsho pmid:3041069
Deguchi K et al. [Blood platelet aggregation]. 1981 Nippon Rinsho pmid:6461781
Kohno S and Nabe T [Inflammatory mediators (leukotrienes, thromboxane A2, tachykinins and others)]. 2001 Nippon Rinsho pmid:11676130
Satoh K et al. [Endothelial injury as an initiating factor: vascular endothelial cell injury and biosynthesis of PAF]. 1988 Nippon Rinsho pmid:3404682
Masugi F et al. [Etiological studies of hypertension. G. APRL (antihypertensive polar renomedullary lipid)]. 1984 Nippon Rinsho pmid:6716685
Sagara H et al. [PAF receptor antagonist in asthma therapy]. 1996 Nippon Rinsho pmid:8950954
Hattori A et al. [Platelets-morphology, shape changing factor, and platelet agglutinating factor. TTP Research Group]. 1993 Nippon Rinsho pmid:8433504
Kuroda M [Eicosanoids and glomerular disease]. 1990 Nippon Rinsho pmid:2384974
Naruse T [Hemolytic uremic syndrome (HUS): pathophysiology--with reference to the differentiation between HUS and thrombotic thrombocytopenic purpura]. 1993 Nippon Rinsho pmid:8433517
Takeda K [Role of increase in permeability and circulatory failure in the development of organ dysfunction in severe acute pancreatitis]. 2004 Nippon Rinsho pmid:15552880
Takase K et al. [New aspects of pharmaco-therapy for acute pancreatitis]. 2004 Nippon Rinsho pmid:15552891
Ushiogi Y et al. [Miscellaneous factors on mechanisms of blood pressure regulation]. 1992 Nippon Rinsho pmid:1635219
Watanabe T [Metabolism and action mechanisms of eicosanoids and platelet-activating factor in the kidney]. 1992 Nippon Rinsho pmid:1337118
Saito H and Tamura Y [Antiatherogenic action of omega-3 polyunsaturated fatty acids]. 1993 Nippon Rinsho pmid:8411664
Kawada I and Takahashi K [A new method for the isolation of peripheral blood eosinophils using flow cytometry (FCM)]. 1993 Nippon Rinsho pmid:8492447
Tsutsui H and Morisawa S [Trend of molecular biological studies on the liver sinusoidal cells--Kupffer cells]. 1993 Nippon Rinsho pmid:8385242
Yanoshita R et al. [Arachidonate cascade and platelet activating factor]. 1990 Nippon Rinsho pmid:2117085
Takizawa H [Eosinophils in immediate allergic reactions]. 1993 Nippon Rinsho pmid:8388063
Tomioka H and Kagami M [Clinical relevance on the inhibition of eosinophil functions--a review with special reference to eosinophilopietic cytokines]. 1993 Nippon Rinsho pmid:8388064